Thompson Davis & Co., Inc. Axogen, Inc. Transaction History

Thompson Davis & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 03, 2018	SELL	$36.15 - $52.5 $4,518 - $6,562	-125 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$24.4 - $40.25 $3,050 - $5,031	125 New	125 $5,000
Q4 2017 Feb 05, 2018	SELL	$18.5 - $28.6 $120,250 - $185,900	-6,500 Closed	0 $0
Q3 2017 Oct 30, 2017	SELL	$14.65 - $19.35 $3,662 - $4,837	-250 Reduced 3.7%	6,500 $126,000
Q2 2017 Aug 10, 2017	BUY	N/A	6,750	6,750 $113,000

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $534M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.